Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Allergy ; 72(12): 1962-1971, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28513859

RESUMEN

BACKGROUND: Asthma is a heterogeneous chronic disease with different phenotypes and treatment responses. Thus, there is a high clinical need for molecular disease biomarkers to aid in differentiating these distinct phenotypes. As MicroRNAs (miRNAs), that regulate gene expression at the post-transcriptional level, are altered in experimental and human asthma, circulating miRNAs are attractive candidates for the identification of novel biomarkers. This study aimed to identify plasmatic miRNA-based biomarkers of asthma, through a translational approach. METHODS: We prescreened miRNAs in plasma samples from two different murine models of experimental asthma (ovalbumin and house dust mite); miRNAs deregulated in both models were further tested in a human training cohort of 20 asthma patients and 9 healthy controls. Candidate miRNAs were then validated in a second, independent group of 26 asthma patients and 12 healthy controls. RESULTS: Ten miRNA ratios consisting of 13 miRNAs were differentially regulated in both murine models. Measuring these miRNAs in the training cohort identified a biomarker signature consisting of five miRNA ratios (7 miRNAs). This signature showed a good sensitivity and specificity in the test cohort with an area under the receiver operating characteristic curve (AUC) of 0.92. Correlation of miRNA ratios with clinical characteristics further revealed associations with FVC % predicted, and oral corticosteroid or antileukotriene use. CONCLUSION: Distinct plasma miRNAs are differentially regulated both in murine and in human allergic asthma and were associated with clinical characteristics of patients. Thus, we suggest that miRNA levels in plasma might have future potential to subphenotype patients with asthma.


Asunto(s)
Asma/diagnóstico , Asma/genética , Biomarcadores , MicroARN Circulante , Transcriptoma , Adulto , Anciano , Animales , Asma/sangre , Modelos Animales de Enfermedad , Femenino , Perfilación de la Expresión Génica , Humanos , Masculino , Ratones , Persona de Mediana Edad , Curva ROC , Reacción en Cadena en Tiempo Real de la Polimerasa , Reproducibilidad de los Resultados , Investigación Biomédica Traslacional , Adulto Joven
2.
Sci Rep ; 12(1): 17679, 2022 10 21.
Artículo en Inglés | MEDLINE | ID: mdl-36271035

RESUMEN

For gene expression analysis, the raw data obtained from RT-qPCR are preferably normalized to reference genes, which should be constantly expressed regardless of experimental conditions. Selection of reference genes is particularly challenging for the developing lung because of the complex transcriptional and epigenetic regulation of genes during organ maturation and injury repair. To date, there are only limited experimental data addressing reliable reference genes for this biological circumstance. In this study, we evaluated reference genes for the lung in neonatal C57BL/6 mice under consideration of biological, technical and experimental conditions. For that, we thoroughly selected candidates from commonly used reference genes side-by-side with novel ones by analyzing publicly available microarray datasets. We performed RT-qPCR of the selected candidate genes and analyzed their expression variability using GeNorm and Normfinder. Cell-specific expression of the candidate genes was analyzed using our own single-cell RNA-sequencing data from the developing mouse lung. Depending on the investigated conditions, i.e., developmental stages, sex, RNA quality, experimental condition (hyperoxia) and cell types, distinct candidate genes demonstrated stable expression confirming their eligibility as reliable reference genes. Our results provide valuable information for the selection of proper reference genes in studies investigating the neonatal mouse lung.


Asunto(s)
Epigénesis Genética , Perfilación de la Expresión Génica , Ratones , Animales , Perfilación de la Expresión Génica/métodos , Ratones Endogámicos C57BL , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , ARN , Pulmón , Estándares de Referencia
3.
Neuroscience ; 157(2): 432-45, 2008 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-18840508

RESUMEN

Glycine is an inhibitory neurotransmitter activating a chloride conductance in the mammalian CNS. In vitro studies from brain slices revealed a novel presynaptic site of glycine action in the medial nucleus of the trapezoid body (MNTB) which increases the release of the excitatory transmitter glutamate from the calyx of Held. Here, we investigate the action of glycine on action potential firing of single MNTB neurons from the gerbil under acoustic stimulation in vivo. Iontophoretic application of the glycine receptor antagonist strychnine caused a significant decrease in spontaneous and sound-evoked firing rates throughout the neurons' excitatory response areas, with the largest changes at the respective characteristic frequency (CF). The decreased firing rate was accompanied by longer and more variable onset latencies of sound-evoked responses. Outside the neurons' excitatory response areas, firing rates increased during the application of strychnine due to a reduction of inhibitory sidebands, causing a broadening of frequency tuning. These results indicate that glycine enhances the efficacy for on-CF stimuli, while simultaneously suppressing synaptic transmission for off-CF stimuli. These in vivo results provide evidence of multiple excitatory and inhibitory glycine effects on the same neuronal population in the mature mammalian CNS.


Asunto(s)
Glicina/metabolismo , Inhibición Neural/fisiología , Neuronas/fisiología , Sinapsis/fisiología , Estimulación Acústica/métodos , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Animales , Lateralidad Funcional , Gerbillinae , Glicina/farmacología , Glicinérgicos/farmacología , Técnicas In Vitro , Iontoforesis/métodos , Inhibición Neural/efectos de los fármacos , Neuronas/citología , Neuronas/efectos de los fármacos , Puente/citología , Psicoacústica , Tiempo de Reacción/efectos de los fármacos , Tiempo de Reacción/fisiología , Sarcosina/análogos & derivados , Sarcosina/farmacología , Estricnina/farmacología , Sinapsis/efectos de los fármacos , Potenciales Sinápticos/efectos de los fármacos , Potenciales Sinápticos/fisiología
4.
Am J Audiol ; 17(2): S193-209, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19056923

RESUMEN

PURPOSE: This review outlines the anatomical and functional bases of somatosensory influences on auditory processing in the normal brainstem and midbrain. It then explores how interactions between the auditory and somatosensory system are modified through deafness, and their impact on tinnitus is discussed. METHOD: Literature review, tract tracing, immunohistochemistry, and in vivo electrophysiological recordings were used. RESULTS: Somatosensory input originates in the dorsal root ganglia and trigeminal ganglia, and is transmitted directly and indirectly through 2nd-order nuclei to the ventral cochlear nucleus, dorsal cochlear nucleus (DCN), and inferior colliculus. The glutamatergic somatosensory afferents can be segregated from auditory nerve inputs by the type of vesicular glutamate transporters present in their terminals. Electrical stimulation of the somatosensory input results in a complex combination of excitation and inhibition, and alters the rate and timing of responses to acoustic stimulation. Deafness increases the spontaneous rates of those neurons that receive excitatory somatosensory input and results in a greater sensitivity of DCN neurons to trigeminal stimulation. CONCLUSIONS: Auditory-somatosensory bimodal integration is already present in 1st-order auditory nuclei. The balance of excitation and inhibition elicited by somatosensory input is altered following deafness. The increase in somatosensory influence on auditory neurons when their auditory input is diminished could be due to cross-modal reinnervation or increased synaptic strength, and may contribute to mechanisms underlying somatic tinnitus.


Asunto(s)
Atención/fisiología , Percepción Auditiva/fisiología , Tronco Encefálico/fisiopatología , Sordera/fisiopatología , Mesencéfalo/fisiopatología , Sensación/fisiología , Acúfeno/fisiopatología , Estimulación Acústica , Vías Aferentes/fisiopatología , Animales , Vías Auditivas/fisiopatología , Mapeo Encefálico , Núcleo Coclear/fisiopatología , Estimulación Eléctrica , Ganglios Espinales/fisiopatología , Humanos , Colículos Inferiores/fisiopatología , Inhibición Neural/fisiología , Plasticidad Neuronal/fisiología , Neuronas/fisiología , Umbral Sensorial/fisiología , Transmisión Sináptica/fisiología , Ganglio del Trigémino/fisiopatología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda